Microbot Medical Inc.
NASDAQ Capital MarketTotal Valuation
Microbot Medical Inc. carries a market capitalization of 89.77M, placing it among publicly traded companies globally. Its enterprise value stands at 50.30M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 89.77M |
| Enterprise Value | 50.30M |
Share Statistics
Microbot Medical Inc. currently has 67.16M shares outstanding.
| Shares Outstanding | 67.16M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 1,160.94, and the price-to-book ratio stands at -1.14.
| PE Ratio | N/A |
| PS Ratio | 1,160.94 |
| PB Ratio | -1.14 |
| P/TBV Ratio | 1.64 |
| P/FCF Ratio | -8.09 |
| P/OCF Ratio | -8.01 |
Enterprise Valuation
| EV / Sales | 479.02 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
Microbot Medical Inc. maintains a current ratio of 22.59, meaning it holds 22.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 22.59 |
| Quick Ratio | 21.44 |
| Debt / Equity | 1.21 |
| Debt / EBITDA | -0.06 |
| Interest Coverage | N/A |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -26.09 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.09 |
Stock Price Statistics
Microbot Medical Inc.'s stock has declined approximately -28.62319% over the past 52 weeks. The 50-day moving average sits at 2.17, while the 200-day moving average is 2.46.
| Beta (5Y) | N/A |
| 52-Week Price Change | -28.62319% |
| 50-Day Moving Average | 2.17 |
| 200-Day Moving Average | 2.46 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Microbot Medical Inc. generated 105,000.00 in revenue and converted that into -14.21M in net income, yielding earnings per share of -0.28. EBITDA reached -16.00M, while operating income came in at -16.04M.
| Revenue | 105,000.00 |
| Gross Profit | 2,000.00 |
| Operating Income | -16.04M |
| Pretax Income | -14.21M |
| Net Income | -14.21M |
| EBITDA | -16.00M |
| EBIT | -16.04M |
| Earnings Per Share (EPS) | -0.28 |
Balance Sheet
Microbot Medical Inc. holds 72.50M in cash and equivalents against 898,000.00 in total debt, resulting in a net debt position of -3.66M. Total book value stands at -107.08M, with working capital of 73.14M providing operational flexibility.
| Cash & Cash Equivalents | 72.50M |
| Total Debt | 898,000.00 |
| Net Debt | -3.66M |
| Equity (Book Value) | -107.08M |
| Book Value Per Share | -2.12 |
| Working Capital | 73.14M |
Cash Flow
Microbot Medical Inc. produced -15.22M in operating cash flow over the past twelve months. After subtracting -155,000.00 in capital expenditures, free cash flow totaled -15.38M - equivalent to -0.30 per share.
| Operating Cash Flow | -15.22M |
| Capital Expenditures | -155,000.00 |
| Free Cash Flow | -15.38M |
| FCF Per Share | -0.30 |
Margins
Microbot Medical Inc. operates with a gross margin of 1.90, reflecting its pricing power and cost economics. The operating margin of -15,278.10 and net profit margin of -13,535.24 provide insight into operational efficiency.
| Gross Margin | 1.90 |
| Operating Margin | -15,278.10 |
| Pretax Margin | -13,535.24 |
| Profit Margin | -13,535.24 |
| EBITDA Margin | -15,236.19 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -47.94 |
| FCF Yield | -12.36 |
Stock Splits
Microbot Medical Inc.'s most recent stock split took place on September 5, 2018 with a 15:1 split ratio.
| Last Split Date | 9/5/2018 |
| Split Ratio | 15:1 |
Scores
Microbot Medical Inc. posts an Altman Z-Score of 16.98, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 16.98 |